Dr. David Liska, MD

Dr. Liska practices at Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation.

Dr. Liska's NPI, 1902063589, was assigned on May 21, 2008. Dr. Liska graduated from Yale University School of Medicine in 2006. Dr. Liska holds New York license 248217-1.

Dr. Liska's primary practice is Cleveland Clinic Main Campus, at 9500 Euclid Avenue, Cleveland, OH 44195 in Cuyahoga County. The practice phone is (216) 952-9829.

Dr. Liska's primary practice is Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation. The medical group on file is Cleveland Clinic. Dmand AI also links Dr. Liska to 2 more clinical labs, each named with a free account. Dr. Liska's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Liska practices, 3 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Liska's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dmand AI has Dr. Liska's licenses on file in 2 states: New York and Ohio.

CMS data shows 119 Medicare services from Dr. Liska across 5 procedure codes in 2024, for 113 Medicare patients. Medicare paid $9,007 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 113 Medicare patients who saw Dr. Liska in 2024. The largest group is 65 to 74, with 65 patients. 70% of them have high blood pressure, and 64% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Liska's median patient age at 57, with 50% women.

In 2024, Dr. Liska wrote 182 Medicare Part D claims for 75 patients. 93% of them were for generic drugs. CMS names the drug for 141 of them, across 5 drugs with 11 or more claims each, at $2,833 in total drug cost. In 2023, CMS named 165 claims across 6 drugs.

Dr. Liska accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Liska as offering telehealth. CMS counts 51 procedures of colonoscopy by Dr. Liska, more than 64% of the clinicians it reports for that procedure.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 132 papers to Dr. Liska, published from 2010 to 2025. 2024 was the busiest year, with 30. The most frequent topics are Colorectal Neoplasms, Rectal Neoplasms and Postoperative Complications. Dr. Liska has published most often in Am J Surg. Dr. Liska's most frequent co-authors are Scott Russell Steele, MD, Stefan David Holubar, MD and Matthew F. Kalady, MD.

Dmand AI links Dr. Liska to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Rectal Neoplasms and Rectal Diseases. Case Comprehensive Cancer Center sponsors the most, 2.

CMS Open Payments shows 68 general payments to Dr. Liska from 22 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 59% of the total. Heron Therapeutics, Inc. paid the most, $8,486.

Dr. Liska graduated from Yale University School of Medicine in 2006.